A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
Obert
- Codi protocol: SNDX-6352-0506
- Codi EudraCT: No aplica
- Grup de recerca: Psiquiatria, Salut Mental i Addiccions
- Servei: Psiquiatria
- Investigador/a principal: Villar Moreno, Ana M
- Malaltia: Malalties del sistema respiratori
- Fase: Fase II
- Estat: Reclutant voluntaris